Shares of Sientra hit a new all-time low on Oct. 16 when the stock fell another six cents on the day and closed at $5.77 per share. For the Goleta-based breast implant manufacturer, it marks another low in a saga that’s starting to turn ugly. Shares of Sientra initially plummeted from $20.58 per share to Read More →
Kythera Biopharmaceuticals is permanently laying off 117 employees at its Westlake Village offices, according to a filing today with the Securities and Exchange Commission. The layoffs come as no surprise and appear to be part of Kythera’s merger with Dublin-based Allergan. On June 17, Allergan announced that it would buy Kythera for $2.1 billion. The Read More →
Thousand Oaks-based pharmaceutical giant Amgen announced results Oct. 12 showing its bone density drug Prolia reduced the incidences of bone fractures in post-menopausal women with osteoporosis over 10 years. Prolia is designed to raise bone density in people with a history of osteoporosis. Amgen released the data during the annual conference of the American Society Read More →
Sientra CEO Hani Zeini sent another letter to plastic surgeons to reassure them that its products are safe. Sientra, a Goleta-based breast implant manufacturer, saw shares drop sharply over the past few months from a high of $23.75 on July 23. In recent weeks the stock fell from $20.58 on Sept. 23 to a close Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Cottage Health Systems and Sansum Clinic moved a step closer to their proposed merger as Cottage found a potential buyer for its Santa Barbara Outpatient Surgery Center, Cottage announced Sept. 28. Cottage tasked New York-based investment banking firm Cain Brothers & Co. to find a possible suitor and they came up with United Surgical Partners International, a Read More →